[go: up one dir, main page]

MX2010005295A - Precursores cationicos de betaina para betainas zwitterionicas que poseen propiedades biologicas controladas. - Google Patents

Precursores cationicos de betaina para betainas zwitterionicas que poseen propiedades biologicas controladas.

Info

Publication number
MX2010005295A
MX2010005295A MX2010005295A MX2010005295A MX2010005295A MX 2010005295 A MX2010005295 A MX 2010005295A MX 2010005295 A MX2010005295 A MX 2010005295A MX 2010005295 A MX2010005295 A MX 2010005295A MX 2010005295 A MX2010005295 A MX 2010005295A
Authority
MX
Mexico
Prior art keywords
cationic
beataine
precursors
biological properties
controlled biological
Prior art date
Application number
MX2010005295A
Other languages
English (en)
Inventor
Shaoyi Jiang
Zheng Zhang
Shengfu Chen
Louisa R Carr
Gang Cheng
Hong Xue
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of MX2010005295A publication Critical patent/MX2010005295A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F120/10—Esters
    • C08F120/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • C08F120/36—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate containing oxygen in addition to the carboxy oxygen, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F120/10—Esters
    • C08F120/38—Esters containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10—Esters
    • C08F20/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • C08F20/36—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate containing oxygen in addition to the carboxy oxygen, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10—Esters
    • C08F20/38—Esters containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/52—Amides or imides
    • C08F20/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10—Esters
    • C08F220/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • C08F220/36—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate containing oxygen in addition to the carboxy oxygen, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Polímeros catiónicos hidrolizables a polímeros zwitteriónicos, monómeros para hacer los polímeros catiónicos, superficies que incluyen los polímeros, sistemas de suministro de un agente terapéutico que incluyen los polímeros catiónicos, métodos para administrar un agente terapéutico utilizando los sistemas de suministro y método para hacer y utilizar los polímeros catiónicos, monómeros, superficies y sistemas de suministro de un agente terapéutico.
MX2010005295A 2007-11-19 2008-11-19 Precursores cationicos de betaina para betainas zwitterionicas que poseen propiedades biologicas controladas. MX2010005295A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98907307P 2007-11-19 2007-11-19
PCT/US2008/084095 WO2009067562A1 (en) 2007-11-19 2008-11-19 Cationic beataine precursors to zwitterionic betaines having controlled biological properties

Publications (1)

Publication Number Publication Date
MX2010005295A true MX2010005295A (es) 2010-06-23

Family

ID=40254461

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010005295A MX2010005295A (es) 2007-11-19 2008-11-19 Precursores cationicos de betaina para betainas zwitterionicas que poseen propiedades biologicas controladas.

Country Status (8)

Country Link
US (3) US8268301B2 (es)
EP (1) EP2227496B1 (es)
JP (2) JP5474808B2 (es)
CN (1) CN101918462B (es)
AU (1) AU2008326438B2 (es)
CA (1) CA2705485C (es)
MX (1) MX2010005295A (es)
WO (2) WO2009067562A1 (es)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110097277A1 (en) 2005-08-25 2011-04-28 University Of Washington Particles coated with zwitterionic polymers
US8706211B2 (en) * 2007-08-17 2014-04-22 The Invention Science Fund I, Llc Systems, devices, and methods including catheters having self-cleaning surfaces
US8647292B2 (en) 2007-08-17 2014-02-11 The Invention Science Fund I, Llc Systems, devices, and methods including catheters having components that are actively controllable between two or more wettability states
US8702640B2 (en) 2007-08-17 2014-04-22 The Invention Science Fund I, Llc System, devices, and methods including catheters configured to monitor and inhibit biofilm formation
US8366652B2 (en) * 2007-08-17 2013-02-05 The Invention Science Fund I, Llc Systems, devices, and methods including infection-fighting and monitoring shunts
US20090048648A1 (en) * 2007-08-17 2009-02-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Self-sterilizing device
US8734718B2 (en) 2007-08-17 2014-05-27 The Invention Science Fund I, Llc Systems, devices, and methods including catheters having an actively controllable therapeutic agent delivery component
US8753304B2 (en) 2007-08-17 2014-06-17 The Invention Science Fund I, Llc Systems, devices, and methods including catheters having acoustically actuatable waveguide components for delivering a sterilizing stimulus to a region proximate a surface of the catheter
US9533006B2 (en) 2007-11-19 2017-01-03 University Of Washington Marine coatings
MX2010005295A (es) * 2007-11-19 2010-06-23 Univ Washington Precursores cationicos de betaina para betainas zwitterionicas que poseen propiedades biologicas controladas.
US10046081B2 (en) 2008-04-11 2018-08-14 The Henry M Jackson Foundation For The Advancement Of Military Medicine, Inc. Electrospun dextran fibers and devices formed therefrom
US20120041287A1 (en) * 2008-12-04 2012-02-16 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems, devices, and methods including implantable devices with anti-microbial properties
EP2384168B1 (en) 2008-12-04 2014-10-08 Searete LLC Actively-controllable sterilizing excitation delivery implants
US8585627B2 (en) 2008-12-04 2013-11-19 The Invention Science Fund I, Llc Systems, devices, and methods including catheters configured to monitor biofilm formation having biofilm spectral information configured as a data structure
US20110160681A1 (en) * 2008-12-04 2011-06-30 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems, devices, and methods including catheters having light removable coatings based on a sensed condition
BR112012006678A2 (pt) 2009-09-25 2016-05-10 Origene Technologies Inc método para criar um arranjo proteico, arranjo proteico e métodos para determinar a especificidade da ligação de um anticorpo ou preparação de anticorpos, para determinar biomarcadores de doenças, para diagnosticar uma doença, para monitorar as vias de transdução de sinais e para determinar interações entre pequenas moléculas e proteínas
WO2011057224A2 (en) * 2009-11-06 2011-05-12 University Of Washington Through Its Center For Commercialization Zwitterionic polymer bioconjugates and related methods
EP2496550B1 (en) 2009-11-06 2015-08-05 University Of Washington Through Its Center For Commercialization Crosslinked zwitterionic hydrogels
WO2011146595A2 (en) * 2010-05-21 2011-11-24 Siemens Healthcare Diagnostics Inc. Zwitterionic reagents
US8857629B2 (en) 2010-07-15 2014-10-14 International Business Machines Corporation Composite membrane with multi-layered active layer
US8709536B2 (en) 2010-09-01 2014-04-29 International Business Machines Corporation Composite filtration membranes and methods of preparation thereof
US8727135B2 (en) 2010-09-01 2014-05-20 International Business Machines Corporation Composite filtration membranes and methods of preparation thereof
US8933173B2 (en) * 2010-11-23 2015-01-13 Chung Yuan Christian University Surface anti-biomolecule agent
US9022227B2 (en) 2011-03-21 2015-05-05 International Business Machines Corporation Composite membranes and methods of preparation thereof
EP2726870B1 (en) 2011-06-29 2018-10-03 Academia Sinica The capture, purification and release of biological substance using a surface coating
CA2872378C (en) 2011-07-20 2016-01-12 University Of Washington Through Its Center For Commercialization Photonic blood typing
FR2979821B1 (fr) * 2011-09-13 2013-10-25 Oreal Procede de traitement cosmetique employant un polymere ethylenique
US10031138B2 (en) 2012-01-20 2018-07-24 University Of Washington Through Its Center For Commercialization Hierarchical films having ultra low fouling and high recognition element loading properties
US9561474B2 (en) 2012-06-07 2017-02-07 International Business Machines Corporation Composite membrane with multi-layered active layer
US9788765B2 (en) * 2012-09-28 2017-10-17 Dexcom, Inc. Zwitterion surface modifications for continuous sensors
EP2925378B1 (en) * 2012-11-30 2019-10-16 University of Massachusetts Medical School Multi-functional surface coating of implants
US11850331B2 (en) 2013-03-11 2023-12-26 Teleflex Medical Incorporated Devices with anti-thrombogenic and anti-microbial treatment
EP2992056A4 (en) * 2013-05-03 2017-12-27 Hempel A/S Novel polysiloxane-based fouling-release coats
WO2014210546A1 (en) 2013-06-27 2014-12-31 University Of Washington Through Its Center For Commercialization Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders
EP3068446A4 (en) * 2013-11-12 2017-08-09 St. Teresa Medical, Inc. Hemostatic products
WO2015153816A2 (en) 2014-04-01 2015-10-08 Academia Sinica Methods and systems for cancer diagnosis and prognosis
JP2016017130A (ja) * 2014-07-08 2016-02-01 互応化学工業株式会社 細菌付着抑制性樹脂
TW201612308A (en) 2014-08-26 2016-04-01 Academia Sinica Collector architecture layout design
CN106999270B (zh) * 2014-09-09 2021-01-01 华盛顿大学 官能化的两性离子和混合电荷聚合物、相关的水凝胶及它们的使用方法
CN111359036A (zh) * 2014-10-02 2020-07-03 旭化成医疗株式会社 源自生物体的液体处理过滤器及过滤器装置
WO2016138528A1 (en) 2015-02-27 2016-09-01 Wayne State University Methods and compositions relating to biocompatible implants
US11512160B2 (en) 2015-06-02 2022-11-29 University Of Washington Free-standing non-fouling polymers, their compositions, and related monomers
US10828387B2 (en) 2015-11-12 2020-11-10 St. Teresa Medical, Inc. Method of sealing a durotomy
US20170188905A1 (en) * 2015-12-30 2017-07-06 Dexcom, Inc. Biointerface layer for analyte sensors
CN108473796B (zh) * 2016-01-20 2020-01-03 阿克佐诺贝尔国际涂料股份有限公司 用于浸入水中的基材的涂料组合物
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
BR112018075841A2 (pt) 2016-06-13 2019-03-19 Massachusetts Institute Of Technology polímero biocompatível, hidrogel, dispositivo, biomaterial e método de preparação do hidrogel
JP2020522534A (ja) 2017-06-06 2020-07-30 ウェイン ステート ユニバーシティＷａｙｎｅ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ カルニチン由来材料に関する方法および組成物
CN107537059B (zh) * 2017-10-01 2020-06-05 山东煜和堂药业有限公司 一种双组份可溶性两性离子水凝胶敷料及其制备方法
WO2019089717A1 (en) 2017-11-02 2019-05-09 St. Teresa Medical, Inc. Fibrin sealant products
EP3781221A4 (en) 2018-04-19 2021-10-20 The Board of Trustees of the University of Illinois ZWITTERIONIC POLYMER COATING FOR BIOMEDICAL APPLICATIONS
US11993670B2 (en) 2018-06-06 2024-05-28 The Board Of Trustees Of The University Of Illinois Zwitterionic biocompatible polymers, methods, and uses thereof
EP3876908A4 (en) * 2018-11-08 2022-07-27 The Governing Council Of The University Of Toronto COMPOSITION AND DEVICE FOR THE PREVENTION OF HYPOGLYCEMIA AND USE THEREOF
US11078394B2 (en) 2019-03-04 2021-08-03 Saudi Arabian Oil Company Cationic coatings for improved nanoparticle transport in a carbonate reservoir
CN112245590B (zh) * 2020-10-14 2022-04-01 燕山大学 一种基于巯基化甜菜碱修饰的阿霉素衍生物、纳米药物及其制备方法
CN113336901B (zh) * 2021-06-25 2022-10-11 河北圣泰材料股份有限公司 一种甜菜碱型两性离子聚合物的制备方法
EP4363461A4 (en) * 2021-06-28 2025-07-09 Tufts College PLANT-INSPIRED ZWITTERIONIC MONOMERS, POLYMERS AND THEIR USES
US20240315242A1 (en) * 2021-07-16 2024-09-26 Lg Chem, Ltd. Antibacterial Compound
US20240352169A1 (en) * 2021-10-29 2024-10-24 Osaka Organic Chemical Industry Ltd. Resin composition, water-swellable film, article covered with water-swellable film, and method for producing water-swellable film
CN115246941B (zh) * 2022-08-25 2024-11-15 西北师范大学 一种多功能自粘附阳离子共聚物水凝胶传感器的制备方法
GB202316849D0 (en) * 2023-11-03 2023-12-20 Univ Bath Wound dressing
CN118599117B (zh) * 2024-03-28 2025-01-24 天津大学 一种可降解的含二硫键的羧基甜菜碱两性离子聚合物及其制备方法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3671502A (en) * 1970-11-12 1972-06-20 Kendall & Co Betaine copolymers with hydroxyalkylacrylates and hydroxyalkylmethacrylates
US4138446A (en) * 1974-12-19 1979-02-06 Sumitomo Chemical Company, Limited Water-soluble high polymers and their preparation
GB1510689A (en) * 1974-12-19 1978-05-10 Sumitomo Chemical Co Preparation of water-soluble cationic high polymer
GB1528616A (en) * 1975-06-04 1978-10-18 Ciba Geigy Ag Alkali-release mordants
US4415388A (en) * 1981-06-22 1983-11-15 Johnson & Johnson Method of making absorbent bearing products
JPS59199696A (ja) * 1983-04-28 1984-11-12 Oki Electric Ind Co Ltd リン脂質類似構造を有する化合物及びポリマ−並びにその製造方法
US4493926A (en) * 1984-01-04 1985-01-15 General Electric Company Dissociating ionically cross-linked siloxane polymers
US5204060A (en) * 1986-01-07 1993-04-20 Berol Kemi Ab Method for disinfection
JPS63234007A (ja) * 1987-03-23 1988-09-29 Kohjin Co Ltd 水溶性が良好なカチオン性重合体
US4985023A (en) * 1988-05-09 1991-01-15 Dow Corning Corporation Antimicrobial superabsorbent articles
US4931328A (en) 1988-08-19 1990-06-05 Hewlett-Packard Company Capillary tube with reduced protein interactions and controllable electroosmotic flow
KR920008095A (ko) 1990-10-01 1992-05-27 원본미기재 수성 전해질 용액의 흡수제로서 사용하기에 적당한 중합체
SU1780673A1 (ru) 1991-04-19 1992-12-15 Tashk Farmatsevticheskij I Фуhгицидhoe cpeдctbo
KR100225234B1 (ko) * 1992-09-24 1999-10-15 손욱 콜레스테릭계 액정 화합물 및 이를 이용한 고분자 분산 액정표시소자
US5624711A (en) * 1995-04-27 1997-04-29 Affymax Technologies, N.V. Derivatization of solid supports and methods for oligomer synthesis
US5714360A (en) * 1995-11-03 1998-02-03 Bsi Corporation Photoactivatable water soluble cross-linking agents containing an onium group
EP0856539A1 (en) * 1997-01-30 1998-08-05 Mitsui Chemicals, Inc. Cross-linked polymer
US7056532B1 (en) 1997-06-13 2006-06-06 Univ. Nebraska Bd. of Regents Compositions for delivery of biological agents and methods for the preparation thereof
US7547445B2 (en) * 1998-03-19 2009-06-16 Surmodics, Inc. Crosslinkable macromers
US6361768B1 (en) 1998-12-29 2002-03-26 Pmd Holdings Corp. Hydrophilic ampholytic polymer
WO2000071591A1 (en) 1999-05-26 2000-11-30 Rhodia Inc. Block polymers, compositions and methods of use for foams, laundry detergents, shower rinses and coagulants
PT1189553E (pt) * 1999-06-24 2004-09-30 Abbott Vascular Devices Ltd Protese endovascular de balao expansivel
US6313246B1 (en) * 1999-07-07 2001-11-06 Nalco Chemical Company High molecular weight zwitterionic polymers
JP3853549B2 (ja) * 1999-11-10 2006-12-06 花王株式会社 機能性アルコール放出物質
US6852816B2 (en) 2000-10-06 2005-02-08 Biocompatibles Uk Limited Zwitterionic polymers
DE10132173A1 (de) * 2001-07-03 2003-01-23 Goldschmidt Ag Th Neue Betainester
US20050058689A1 (en) * 2003-07-03 2005-03-17 Reactive Surfaces, Ltd. Antifungal paints and coatings
DE10261750A1 (de) 2002-12-30 2004-07-15 Basf Ag Ampholytisches Copolymer und dessen Verwendung
SE0400073D0 (sv) * 2003-04-04 2004-01-14 Appear Sweden Hb Antibacterial material
EP1624754B1 (en) 2003-05-15 2011-02-09 Arch UK Biocides Limited Antimicrobial composition containing a polymeric biguanide and a copolymer and use thereof
US7291427B2 (en) * 2004-03-19 2007-11-06 Fujifilm Corporation Surface graft material, conductive pattern material, and production method thereof
US20060183863A1 (en) 2005-02-14 2006-08-17 Ciphergen Biosystems, Inc. Zwitterionic polymers
TWI326691B (en) * 2005-07-22 2010-07-01 Kraton Polymers Res Bv Sulfonated block copolymers, method for making same, and various uses for such block copolymers
CN101287805B (zh) * 2005-09-06 2011-11-02 诺华丝国际股份有限公司 海洋防污涂料组合物
US8124128B2 (en) 2005-11-08 2012-02-28 Industrial Technology Research Institute Amphiphilic block copolymers and nano particles comprising the same
FR2894585B1 (fr) * 2005-12-14 2012-04-27 Rhodia Recherches Et Tech Copolymere comprenant des unites zwitterioniques et d'autres unites, composition comprenant le copolymere, et utilisation
DE102006004111B4 (de) 2006-01-28 2015-11-19 Wöhlk-Contact-Linsen GmbH Kontaktlinsenmaterial
FR2898067B1 (fr) 2006-03-03 2008-05-30 Rhodia Recherches & Tech Modification de surfaces solides par des associations de polymeres
US20080311045A1 (en) 2007-06-06 2008-12-18 Biovaluation & Analysis, Inc. Polymersomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
MX2010005295A (es) * 2007-11-19 2010-06-23 Univ Washington Precursores cationicos de betaina para betainas zwitterionicas que poseen propiedades biologicas controladas.

Also Published As

Publication number Publication date
JP5474808B2 (ja) 2014-04-16
JP2011504526A (ja) 2011-02-10
JP2014012861A (ja) 2014-01-23
CN101918462A (zh) 2010-12-15
US8268301B2 (en) 2012-09-18
EP2227496B1 (en) 2014-10-29
CA2705485C (en) 2016-03-08
US20130011363A1 (en) 2013-01-10
EP2227496A1 (en) 2010-09-15
CN101918462B (zh) 2013-07-17
WO2009067562A1 (en) 2009-05-28
US20090156460A1 (en) 2009-06-18
WO2009067566A1 (en) 2009-05-28
US8404224B2 (en) 2013-03-26
AU2008326438A1 (en) 2009-05-28
AU2008326438B2 (en) 2014-09-04
US20100247614A1 (en) 2010-09-30
CA2705485A1 (en) 2009-05-28

Similar Documents

Publication Publication Date Title
MX2010005295A (es) Precursores cationicos de betaina para betainas zwitterionicas que poseen propiedades biologicas controladas.
WO2007146426A3 (en) Nanoshells for drug delivery
WO2011057225A3 (en) Self-assembled particles from zwitterionic polymers and related methods
GB2477046B (en) Devices,systems and methods for medicament delivery
TW200728329A (en) Preparation and application of high refraction polymers
ZA201000588B (en) Improved pharmaceutical-coated medical products,the production thereof and the use thereof
WO2008036144A3 (en) Nanoshells on polymers
GB0910105D0 (en) Devices, systems and methods for medicament delivery
WO2009055306A3 (en) Coating designs for the tailored release of dual drugs from polymeric coatings
MX2010009222A (es) Soluciones farmaceuticas, proceso de preparacion y usos terapeuticos.
GB2451769B (en) Devices, systems, and methods for medicament delivery
IL201479A (en) Use of tapentadol for the preparation of pain medication
WO2010014690A3 (en) Medical devices for therapeutic agent delivery
WO2008048471A3 (en) Obstructive sleep apnea treatment devices, systems and methods
IL210589A (en) C2386RV Protein Tuberculosis Kvfb Protein Use for the Treatment or Prevention of TB
WO2009141823A3 (en) Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases
WO2010135418A3 (en) Implantable medical devices for therapeutic agent delivery
WO2008154143A3 (en) Elastomeric copolymer coatings for implantable medical devices
GB2477227B (en) Devices, systems and methods for medicament delivery
WO2010120389A8 (en) Polymeric drug delivery systems and processes for producing such systems
WO2008154132A3 (en) Implantable medical devices with elastomeric block copolymer coatings
GB201114400D0 (en) Devices, systems and methods for medicament delivery
MY146657A (en) Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas
WO2010150098A3 (en) Use of quingolide in the treatment of endometriosis, pain and cancer
MX2009011214A (es) Uso de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4-piridin-4-il)- 5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos craneales.

Legal Events

Date Code Title Description
FG Grant or registration